GENEVA – The World Health Organization (WHO) states, among hundreds of Covid-19 vaccine candidates, a candidate vaccine developed by AstraZeneca is the most advanced candidate in terms of development, cited Sindonews.
This British pharmaceutical company is collaborating with Oxford University in carrying out the vaccine, and has entered a trial phase in humans.
Kepala Ilmuwan WHO, Soumya Swaminathan mengatakan, Moderna juga berada tidak jauh di belakang AstraZeneca. Of the approximately 200 candidates for the corona vaccine, 15 have entered clinical trials.
Meanwhile, the WHO claimed to have been in talks with several Chinese manufacturers, including Sinovac about a potential vaccine.
The purpose of the fundraiser was intuk develop and deliver tests, treatments, and vaccines of the corona virus. In the distribution of funds over the years, WHO in collaboration with drug development organization, financing and distribution hub called ACT-Accelerator.
This initiative is intended to develop and deliver 500 million corona tests and 245 million new treatment programs, to low and middle income countries by mid-2021.
WHO also hopes that 2 billion doses of vaccine, including 1 billion that will be purchased by low and middle income countries, will be available by the end of 2021.
(ahl)
–
